martin_shkreli_2016

‘Pharma bro’ Shkreli heads to jail

September 14, 2017
Medical Communications Martin Shkreli, Shkreli, biotech, drugs, pharma, pharmaceutical

Martin Shkreli’s habit of being unable to stay out of the headlines continues, although this time with the repercussion that …

shutterstock_159488225

Amicus pulls plug on rare skin disease drug after Phase 3 failure

September 14, 2017
Research and Development Amicus, epidermolysis bullosa, pharma, pharmaceutical, trial failure

New Jersey-based biotech firm Amicus Therapeutics has been forced to terminate its development of its candidate for treating rare skin …

antibiotic_sensitvity_and_resistance

UK collaboration presents promising data in the fight against antibiotic resistance

September 13, 2017
Research and Development Auspherix, antibiotic resistance, domainex, pharma

The collaborative efforts of Domainex and Auspherix have made new progress in the development of a solution to the growing …

sanofi_regeneron

Sanofi/Regeneron new asthma data bolstered by potential indications

September 13, 2017
Research and Development Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and Regeneron’s Dupixent is predicted to grow to be one of the largest selling drugs in the industry but …

Novartis’ Cosentyx proves long-term efficacy in psoriasis skin clearance

September 13, 2017
Research and Development Cosentyx, Novartis, pharma, pharmaceutical, psoriasis

At the European Academy of Dermatology and Venereology Congress in Geneva, Switzerland, Novartis unveiled new Phase 3 data for Cosentyx …

23andme

23andMe raises $250m in financing, research points towards its future

September 13, 2017
Research and Development, Sales and Marketing 23andME, biotech, drugs, pharma, pharmaceutical

23andMe made two announcements on the same day that point towards the future of its business: it revealed it had …

Recipharm and CTC launch integrated first in human service

September 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm, biotech, drugs, pharma, pharmaceutical

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch …

virus-1812092_960_720

Newly adopted flu vaccine could save 1,700 lives

September 12, 2017
Research and Development, Sales and Marketing biotech, drugs, flu, fluad, pharma, pharmaceutical, seqirus

The Fluad flu vaccine, produced by Seqirus, was approved by the MHRA for use beginning in 2018 and further data …

J&J backs out of $1.1 billion hep C deal, wiping 22.2% from Achillion’s stock

September 12, 2017
Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, achillion, hepatitis C, pharma

Johnson & Johnson has announced that it is to back out of a $1.1 billion deal with Achillion Pharmaceuticals to …

Teva announces sale of Paragard for $1.1 billion

September 12, 2017
Manufacturing and Production, Sales and Marketing Paragard, Teva, biotech, drugs, pharma, pharmaceutical

Shortly after the news that Teva had finally sealed the deal on a new CEO, it also announced that it …

FDA accepts license application for Novartis’ rituximab biosimilar

September 12, 2017
Manufacturing and Production, Sales and Marketing Novartis, Rituxan, Sandoz, biosimilar, rituximab

Sandoz, Novartis’ generics and biosimilars division, has revealed that the FDA has accepted its Biologics License Application (BLA) for a …

Questions raised after two deaths in AbbVie arthritis study

September 12, 2017
Manufacturing and Production, Research and Development AbbVie, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis

AbbVie’s rheumatoid arthritis drug, upadacitinib, is the company’s big plan to manage the inevitable loss of sales from Humira, as …

new_brand_image_sept_2017

PrimeVigilance launches new brand and logo

September 12, 2017
Manufacturing and Production, Sales and Marketing pharmacovigilance, primevigilance

PrimeVigilance has launched its new visual identity together with a new website. Additionally, it has begun harmonising its appearance within …

ian_w

Ipsen announces new Vice President of Corporate External Communications

September 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen

French biopharmaceutical group Ipsen has announced that Dr Ian Weatherhead has taken up the position of Vice President, Corporate External …

alzheimers-749616_960_720

Alzheimer’s disease: Fighting back against a growing threat

September 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's UK, dementia, life sciences, pharma

September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark …

lonely-1822414_960_720

Mental health crisis as UK struggles with number of psychiatrists

September 11, 2017
Business Services, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical, psychiatry

Research undertaken by the Royal College of Psychiatrists using data from NHS Digital has found that the number of psychiatrists …

Lilly’s Cyramza combo boasts strong results in bladder cancer

September 11, 2017
Research and Development, Sales and Marketing Eli Lilly, bladder cancer, cyramza, immunotherapy, pharma

Eli Lilly has announced new Phase 3 data at the European Society for Medical Oncology 2017 Congress which further add …

novartis_window

Melanoma treatment: Novartis posts success, Roche stumbles

September 11, 2017
Research and Development, Sales and Marketing Novartis, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …

astrazeneca_plaque

AstraZeneca’s Tagrisso beats standard of care in halting NSCLC

September 11, 2017
Research and Development, Sales and Marketing AstraZeneca, ESMO, NSCLC, Tagrisso, non-small cell cell cancer, pharma, pharmaceutical

AstraZeneca has revealed new data at the European Society of Medical Oncology (ESMO) on the efficacy of Tagrisso (osimertinib) in …

29863293981_33b910b458_z

Teva finally announces successful CEO appointment

September 11, 2017
Medical Communications, Sales and Marketing Lundbeck, Teva, biotech, drugs, pharma, pharmaceutical

Teva has announced that its protracted search for a new CEO has finally come to end, as it revealed the …

The Gateway to Local Adoption Series

Latest content